SPECIALTY PHARMACY ACCREDITATION V3.0 MANDATORY MEASURES

Similar documents
SPECIALTY PHARMACY MANDATORY MEASURES

2017 URAC SPECIALTY PHARMACY PERFORMANCE MEASUREMENT: AGGREGATE SUMMARY PERFORMANCE REPORT

Chapter 17: Pharmacy and Drug Formulary

Pharmaceutical Management Community Plans 2018

Pharmaceutical Management Commercial Plans

Pharmaceutical Management Medicaid 2017

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

Prescription Drug Plan Update

Blue Essentials, Blue Advantage HMO SM and Blue Premier SM Provider Manual - Pharmacy

Pharmaceutical Management Medicaid 2018

Understanding Your Prescription Program. CCIU Employee Meeting September 7, 2016

Innovative Strategies for Managing the Rising Cost of Specialty Drugs

Get the most from your prescription benefit

21 - Pharmacy Services

Summary of 2017 Medicare Part D Final Call Letter

Get the most from your

PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE

Princeton University Prescription Drug Plan Summary Plan Description

Chapter 21. Pharmacy Services

April 8, 2019 VIA Electronic Filing:

IMPLEMENTATION GUIDE AB 339: Outpatient Prescription Drugs

Wyoming Medicaid Prior Authorization Program. Provider Training Manual

Glossary of Terms (Terms are listed in Alphabetical Order)

Insurance & Medication Access

Modernizing Louisiana s Medicaid

Your Prescription Drug Benefit Handbook

Chapter 10 Prescriptions Benefits and Drug Formulary

Medicare Part D Transition Policy CY 2018 HCSC Medicare Part D

$8,300 $24,900 Maximum Lifetime Benefit

$4,800 $9,600 Maximum Lifetime Benefit

Get the most from your prescription-drug benefit

RE: Medicare Coverage Gap Discount Program Appeals Guidance

PEP-Portland Clinical Practices Policy Number: CP Policy Owner: Health Plan Operations Manager New Revised Reviewed

The Impact of Adherence Quality Measures on the US Healthcare Marketplace

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:

MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT. Specialty Drug Management

Indiana Health Coverage Program Seminar Presented by MDwise Pharmacy October 22-24, 2007 P0153 (9/07)

Stevens Institute of technology

MEDICAL ASSISTANCE HANDBOOK

SecurityBlue HMO. Link to Specific Guidance Regarding Exceptions and Appeals

ACTIVELY MANAGED DRUG SOLUTIONS SPECIALTY DRUGS. Supporting employees and building sustainable drug plans...together

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter July 1, 2016 through September 30, 2016

MEDICAL ASSISTANCE HANDBOOK

Excellus BlueCross BlueShield Participating Provider Manual. 5.0 Pharmacy Management

Share a Clear View. El Paso Children's Hospital. Printed on:

BlueRx PDP. Link to Specific Guidance Regarding Exceptions and Appeals

Draft Released: February 1, Final Released: April 2, Effective Date: January 1, 2019

Managing Specialty Pharmaceuticals: Balancing Access and Affordability

UC SHIP Premium Formulary. Effective September 1, 2016

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 1/18/18 SECTION: DRUGS LAST REVIEW DATE: 8/13/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Arkansas State University System Prescription Drug Program

10.1 Summary Prescription drug coverage for you and your eligible Dependents Three-tier Copayment plan Retail and maintenance programs

PURPOSE OF THE POLICY STATEMENT OF THE POLICY PROCEDURES

Florida Medicaid Prescribed Drug Service Spending Control Initiatives

Survey Analysis of January 2014 CMS Medicare Part D Proposed Rule

2014 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual Release Notes 01/23/2014

Florida Medicaid Prescribed Drug Service Spending Control Initiatives. For the Quarter April 1, 2016 through June 30, 2016

The Management of Specialty Drugs: Opportunities and Challenges

Update. The authors of this article are all consultants with Huron Consulting Group, which serves the continuum of life sciences organizations

Get the most out of your pharmacy benefit.

2019 Transition Policy and Procedure

Individual Business Prescription Drug Utilization Management Changes Frequently Asked Questions

Authorizations & Notifications

CDHP Special Administration

SPD Prescription Drugs Plan

WHITE PAPER How Consumer-Driven Healthcare Can Drive Down Costs for Payers

Partnership for Part D Access

Co-pay Accumulator Adjustment Programs

REQUEST FOR MEDICARE PRESCRIPTION DRUG COVERAGE DETERMINATION This form may be sent to us by mail or fax:

Oklahoma Higher Education Employee Insurance Group 2014 benefit plan Y0066_130717_100929

WELCOME. Your search for prescription benefit savings is now over.

Martin s Point Generations Advantage Policy and Procedure Form

2018 Transition Fill Policy & Procedure. Policy Title: Issue Day: Effective Dates: 01/01/2018

1 INSURANCE SECTION Instructions: This section contains information about the cardholder and their plan identification.

Enrollment Form for ENTRESTO Central Patient Support Program

Best Practice Recommendation for

Archived 12.1 THE BASIS FOR ESTABLISHING A RATE OF PAYMENT DETERMINING A FEE... 2

Summary of Benefits. Albemarle Choice HDHP-HSA. (Plan uses KeyCare PPO. providers)

2014 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual Release Notes 12/13/2013

Prescription Benefits State of Maryland. CVS Caremark manages your prescription drug benefit under a contract with the State of Maryland.

Council of State Governments Policy Academy Series. Policy Issues for State Legislators. November 21, 2014

Prescription Drug Specialty Tiers in Pennsylvania

Medical Benefits Trust

Questions and Answers. When should I use mail order pharmacy services? What is my co payment for drugs? What is my co payment for preferr

Health Savings Plan (HSP)

2019 Pre-Medicare Retiree Healthcare Open Enrollment

Chapter 9: What to do if you have a problem or complaint (coverage decisions, appeals, complaints)

Coverage Period: 01/01/ /31/2015 Coverage for: Individual and/or Family

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Medication Limitation of Non Coverage for Prevention Benefit Coverage with Waived Cost Share

Co-payment Summary Co-payment is the dollar amount paid by the member for each covered prescription

2015 PacificSource Medicare Part D Transition Process for contracts H3864 & H4754:

2019 Pre-Medicare Retiree Healthcare Open Enrollment

Appendix. Year Total drug spending reaching catastrophic coverage, $

Value Three-Tier EFFECTIVE DATE: 01/01/2016 FORM #1779_03

PHARMACY BENEFIT MEMBER BOOKLET

UNDERSTANDING & MAKING THE MOST OF YOUR PHARMACY BENEFITS

Before prescribing ZYTIGA (abiraterone acetate), please see accompanying full Prescribing Information. Help simplify starting and staying on ZYTIGA

Pharmacy Benefit Strategies for Lowering Prescription Drug Costs

MEDICARE PART D PRESCRIPTION DRUG BENEFIT

Transcription:

MANDATORY S Note: Mandatory measures are those measures that are a requirement of accreditation and must be reported to on an annual basis. # DESCRIPTION NUMERATOR DENOMINATOR DATA SOURCE DM2012-13 Drug-Drug Interactions Safe Care This measure assesses the percentage of patients who received a prescription for a target medication during the measurement period and who were dispensed a concurrent prescription for a precipitant medication. Stratify by Commercial, Medicaid, and Medicare (i.e., report each product line separately). The number of patients who were dispensed a concurrent precipitant medication during the Patients who received a target medication. ; DTM 2010-04 Call Center Performance Health Care Mgmt This measure has two parts: Part A evaluates the percentage of calls during normal business hours to the organization s call service center(s) during the measurement period that were answered by a live voice within 30 seconds; Part B evaluates the percentage of calls made during normal business hours to the organization s call service center(s) during the reporting year that were abandoned by callers before being answered by a live customer service representative. calls answered by a live customer service representative within 30 seconds of being placed in the organization s ACD call queue. Part B: The number of calls abandoned by callers after being placed in the ACD call queue and before being answered by a live customer service representative. calls received by the organization s call service center during normal business hours during the Automatic Call Distribution (ACD)

MANDATORY S # MP2012-06 Dispensing Accuracy Safe Care This six-part measure and composite roll-up assesses the percentage of prescriptions that the organization dispensed inaccurately. DESCRIPTION NUMERATOR DENOMINATOR DATA SOURCE Measure parts include: (A) Incorrect Drug and/ or Product Dispensed; (B) Incorrect Recipient; (C) Incorrect Strength; (D) Incorrect Dosage Form; (E) Incorrect Instructions; (F) Incorrect Quantity. in which an incorrect drug and/or product was dispensed. Part B: The number of drugs and products in the denominator that were dispensed to an incorrect recipient. Part C: The number of prescriptions in were dispensed at an incorrect strength. Part D: The number of prescriptions in were dispensed in an incorrect dosage form. Part E: The number of that were dispensed with incorrect patient instructions. Part F: The number of drugs and products in the denominator that were dispensed as an incorrect quantity. Roll up Methodology: Sum numerator parts A - F. dispensed by the organization to or on behalf of a specific patient during the

MANDATORY S # MP2012-07 Distribution Accuracy Safe Care This measure assesses the percentage of prescriptions delivered to the wrong recipient. Part A measures the percentage of prescriptions mailed with an incorrect address; Part B measures the percentage of prescriptions mailed with a correct address that were not delivered to the correct location. DESCRIPTION NUMERATOR DENOMINATOR DATA SOURCE in were dispensed with an incorrect address. Part B: The number of in were delivered to the wrong location despite having the correct address on the package. dispensed by the organization to or on behalf of a specific patient during the MP2012-08 Turnaround Time for Prescriptions Health Care Mgmt This 3-part measure assesses the average speed with which the organization fills prescriptions, once the prescription is clean. Part A measures prescription turnaround time for clean prescriptions; Part B measures prescription turnaround time for prescriptions that required intervention; and Part C measures prescription turnaround time for all prescriptions. Part A, B, C: The sum of business days to fill prescriptions in the denominator (n1 + n2 + nx, where n1 = the number of business days to schedule delivery of prescription 1, n2 = the number of business days to schedule delivery of prescription 2 nx = the number of business days to schedule delivery of prescription x). Part A: Total number of drugs and products that arrived clean and Part B: Total number of prescriptions that initially required intervention and Part C: Total number of prescriptions the organization

EXPLORATORY S Note: Exploratory measures are measures on the cutting edge, meaning that either the industry has not come to consensus on how to measure a particular concept or the measure is experimental or in development. In the case of exploratory measure, the organization has the option to report. # DESCRIPTION NUMERATOR DENOMINATOR DATA SOURCE DM2012-12 Proportion of Days Covered (PDC) -- Specialty Measures percentage of participants 18 years and older who met the proportion of days covered (PDC) threshold of 80% during the measurement year. A separate rate is calculated for the following medications: Multiple Sclerosis medications (TBD by PQA*); Hepatitis C medications (TBD by PQA); Rheumatoid Arthritis medications (TBD by PQA), Antiretroviral (this measure has a threshold of 90% for at least 2 medications). The number of patients who met the PDC threshold during the measurement year. Members 18 years and older as of the last day of the measurement period who filled two or more prescriptions with 150 days between the first fill and the last fill, over a 12- month period. Claims; SP2012-09 Fulfillment of Promise to Deliver Process * Note: those indicated as TBD by PQA are currently pending adoption by the Measure Steward. This measure assesses the percentage of prescriptions delivered on time. Number of prescriptions in patients received on the date scheduled for delivery. prescriptions that the organization Administrative ;

EXPLORATORY S # PH2015-01 PH2015-05 Primary Medication Non- Adherence Consumer Experience with Services DESCRIPTION NUMERATOR DENOMINATOR DATA SOURCE The percentage of prescriptions for chronic medications e-prescribed by a prescriber and not obtained by the patient in the following 30 days. This rate measures the level of primary medication non-adherence across a population of patients. Survey Domains: Staff Communication, Information about Medicine, Written Information, New Prescriptions, and About You. The number of e-prescribing transactions in the denominator where there was no pharmacy dispensing event that matched the patient and the prescribed drug or appropriate alternative drug within 30 days following the e-prescribing event. The number of e-prescriptions for newly initiated drug therapy for Chronic Medications for PMN during the measurement period and for the eligible population. ; Electronic Clinical : N/A N/A PQA Survey * Please note that PH2015-05, Consumer Experience with Services, is not in the body of the 2017 Measures Reporting Instructions. Measure details are available in a separate addendum entitled, Addendum to Management Measure Specifications Measure PH2015-05, located within the Resources section of AccreditNet 2.0.